Meridian Bioscience (VIVO) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.90 --0%
Financial Fact:
DIVIDENDS DECLARED PER COMMON SHARE: 0.2
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
DIVIDENDS DECLARED PER COMMON SHARE: 0.2
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.13, $0.02 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $49 million versus the consensus estimate of $48.05 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- iQIYI (IQ) Misses Q2 EPS by 21c
- Hesai Group (HSAI) Tops Q1 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
